Mykofungin 3 Kombi (Clotrimazole)

Clotrimazole, the active ingredient in Mykofungin 3 Kombi, is an azole antifungal presented as a topical formulation for cutaneous and vaginal use. It treats superficial candidiasis of the skin and mucous membranes in both adults and children.

GNH USA supplies Mykofungin 3 Kombi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mykofungin 3 Kombi, an azole antifungal, is employed to manage fungal infections of the skin and mucosa. - Cutaneous candidiasis: reduces fungal growth, relieving redness, itching and scaling. - Vaginal candidiasis: alleviates discharge, itching and irritation caused by yeast infection. - Intertriginous candidiasis: treats fungal infection in skin folds, improving comfort and preventing spread.

Clotrimazole is generally well tolerated, but local reactions can occur.

Common Side Effects: - Burning sensation at the application site. - Mild itching or redness. - Dryness or peeling of the skin. - Slight stinging when first applied.

Serious or Rare Side Effects: - Severe allergic reaction (rash, swelling, difficulty breathing). - Contact dermatitis with extensive blistering. - Persistent irritation or ulceration of the mucosa.

Before using Mykofungin 3 Kombi, consider the following safety measures. - Avoid use on broken or inflamed skin: may increase irritation. - Do not use if you have a known allergy to clotrimazole or other azole antifungals. - Limit prolonged application: extended use can promote fungal resistance. - Consult a healthcare professional before use during pregnancy or breastfeeding. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Clotrimazole may interact with other agents applied to the same area or systemic medications.

Major Interactions (Avoid): - Concurrent use of other topical azole products: may increase local irritation. - Application over areas treated with corticosteroid creams: can enhance skin thinning.

Moderate Interactions (Monitor Closely): - Use with systemic azole antifungals: may increase overall azole exposure. - Co‑administration with warfarin: monitor INR as a precaution, although topical exposure is minimal.